COR vs CTVA · P/E 21, rev $321.33B vs P/E 42, rev $16.91B
Cencora Inc. (COR) versus Corteva Inc (CTVA) — a side-by-side from cached financials, not a winner call.
Cencora Inc. (COR) is a medical distribution company listed on NYSE.
Corteva Inc (CTVA) is a agricultural inputs company listed on US.
Latest reported COR revenue for 2025-09-30 was $321.33B. Net income was $1.57B. Revenue was up 9.3% from 2024-09-30 to 2025-09-30. COR currently screens at market cap $53.91B and trailing P/E 21.2.
Latest reported CTVA revenue for 2024-12-31 was $16.91B. Net income was $919.0M. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
COR currently screens at market cap $53.91B and trailing P/E 21.2. CTVA currently screens at market cap $51.52B and trailing P/E 41.6.
Not investment advice. Open the COR and CTVA stock pages for the full models.
Not investment advice.